The papers for presentation by Steven Beier, Joe Bergan and Trent Watkins are:
Kappos L, Comi G, Panitch H, Oger J, Antel J, Conlon P, Steinman L and
the APL in Relapsing MS Study Group. Induction of
a non-encephalitogenic Th2 autoimmune response in multiple sclerosis after
administration of an altered peptide ligand in a placebo controlled, randomized
phase II trial. Nature Medicine, 6(10)1176-1182, 2000.
Garren H, Pedro J. Ruiz, Trent A. Watkins, Paulo Fontoura, Louis-Vu
T. Nguyen, Einat R. Estline, David L. Hirschberg, and Lawrence Steinman.
Combination of Gene Delivery and DNA Vaccination to
Protect from and Reverse Th1 Autoimmune Disease Via Deviation to the Th2
Pathway. Immunity, 1515-22, 2001.
Chabas D, Baranzini S, Mitchell D, Bernard CCA, Rittling S, Denhardt, D, Sobel R, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg J, Steinman L. The influence of the pro-inflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science, in press.